BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 34579762)

  • 21. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers.
    Weng D; Penzner JH; Song B; Koido S; Calderwood SK; Gong J
    Breast Cancer Res; 2012 Jan; 14(1):R18. PubMed ID: 22277639
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequent overexpression of AMAP1, an Arf6 effector in cell invasion, is characteristic of the MMTV-PyMT rather than the MMTV-Neu human breast cancer model.
    Otsuka Y; Oikawa T; Yoshino H; Hashimoto S; Handa H; Yamamoto H; Hashimoto A; Sabe H
    Cell Commun Signal; 2018 Jan; 16(1):1. PubMed ID: 29329590
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.
    Kündig P; Giesen C; Jackson H; Bodenmiller B; Papassotirolopus B; Freiberger SN; Aquino C; Opitz L; Varga Z
    J Transl Med; 2018 May; 16(1):118. PubMed ID: 29739401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptomic dynamics of breast cancer progression in the MMTV-PyMT mouse model.
    Cai Y; Nogales-Cadenas R; Zhang Q; Lin JR; Zhang W; O'Brien K; Montagna C; Zhang ZD
    BMC Genomics; 2017 Feb; 18(1):185. PubMed ID: 28212608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells.
    Cheng YH; Chen YC; Lin E; Brien R; Jung S; Chen YT; Lee W; Hao Z; Sahoo S; Min Kang H; Cong J; Burness M; Nagrath S; S Wicha M; Yoon E
    Nat Commun; 2019 May; 10(1):2163. PubMed ID: 31092822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits.
    Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE
    Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.
    Hamelin B; Obradović MMS; Sethi A; Kloc M; Münst S; Beisel C; Eschbach K; Kohler H; Soysal S; Vetter M; Weber WP; Stadler MB; Bentires-Alj M
    J Mammary Gland Biol Neoplasia; 2023 Dec; 28(1):26. PubMed ID: 38066300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
    Alberti L; Losi L; Leyvraz S; Benhattar J
    PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD44 attenuates metastatic invasion during breast cancer progression.
    Lopez JI; Camenisch TD; Stevens MV; Sands BJ; McDonald J; Schroeder JA
    Cancer Res; 2005 Aug; 65(15):6755-63. PubMed ID: 16061657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell specific CD44 expression in breast cancer requires the interaction of AP-1 and NFκB with a novel cis-element.
    Smith SM; Cai L
    PLoS One; 2012; 7(11):e50867. PubMed ID: 23226410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.
    Patsialou A; Wang Y; Lin J; Whitney K; Goswami S; Kenny PA; Condeelis JS
    Breast Cancer Res; 2012 Oct; 14(5):R139. PubMed ID: 23113900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
    McBryan J; Fagan A; McCartan D; Bane FT; Varešlija D; Cocchiglia S; Byrne C; Bolger J; McIlroy M; Hudson L; Tibbitts P; Gaora PÓ; Hill AD; Young LS
    Clin Cancer Res; 2015 Dec; 21(23):5371-9. PubMed ID: 26240272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
    Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
    Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity.
    Rappa G; Mercapide J; Lorico A
    Am J Pathol; 2012 Jun; 180(6):2504-15. PubMed ID: 22542847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lgr5+CD44+EpCAM+ Strictly Defines Cancer Stem Cells in Human Colorectal Cancer.
    Leng Z; Xia Q; Chen J; Li Y; Xu J; Zhao E; Zheng H; Ai W; Dong J
    Cell Physiol Biochem; 2018; 46(2):860-872. PubMed ID: 29627827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-expression of miR-21 contributes to migration and invasion by inducing epithelial-mesenchymal transition consistent with cancer stem cell characteristics in MCF-7 cells.
    Han M; Liu M; Wang Y; Mo Z; Bi X; Liu Z; Fan Y; Chen X; Wu C
    Mol Cell Biochem; 2012 Apr; 363(1-2):427-36. PubMed ID: 22187223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.